Cargando…

Prostate cancer screening and the management of clinically localized disease

Detalles Bibliográficos
Autores principales:	Wilt, Timothy J, Ahmed, Hashim U
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2013
Materias:	Clinical Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938276/ https://www.ncbi.nlm.nih.gov/pubmed/23360718 http://dx.doi.org/10.1136/bmj.f325

Ejemplares similares

Defining the level of evidence for technology adoption in the localized prostate cancer pathway
por: Valerio, Massimo, et al.
Publicado: (2014)

Is there an optimal management for localized prostate cancer?
por: Singh, Jaspreet, et al.
Publicado: (2010)

False-positive screening results in the Finnish prostate cancer screening trial
por: Kilpeläinen, T P, et al.
Publicado: (2010)

Doxazosin in the treatment of benign prostatic hypertrophy: an update
por: Wilt, Timothy J, et al.
Publicado: (2006)

Significance of Image Guidance to Clinical Outcomes for Localized Prostate Cancer
por: Zhong, Qiuzi, et al.
Publicado: (2014)

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial
por: Määttänen, L, et al.
Publicado: (2007)

Management of Localized Prostate Cancer by Focal Transurethral Resection of Prostate Cancer: An Application of Radical TUR-PCa to Focal Therapy
por: Morita, Masaru, et al.
Publicado: (2012)

Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors
por: Wever, E M, et al.
Publicado: (2013)

Reactions to Recommendations and Evidence About Prostate Cancer Screening Among White and Black Male Veterans
por: Danan, Elisheva R., et al.
Publicado: (2021)

Lower urinary tract symptoms in men
por: Hollingsworth, John M, et al.
Publicado: (2014)

Targeting the cancer lesion, not the whole prostate
por: Bedi, Nishant, et al.
Publicado: (2020)

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kaapu, Kalle J, et al.
Publicado: (2016)

Perspectives on the clinical management of localized prostate cancer
por: Nelson, Joel B
Publicado: (2014)

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
por: Heijnsdijk, E A M, et al.
Publicado: (2009)

The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review
por: Valerio, Massimo, et al.
Publicado: (2014)

Management of High-Risk Localized Prostate Cancer
por: Marciscano, Ariel E., et al.
Publicado: (2012)

Focal Therapy in the Management of Prostate Cancer: An Emerging Approach for Localized Prostate Cancer
por: Nomura, Takeo, et al.
Publicado: (2012)

Altering the Natural History of Oligometastatic Prostate Cancer With Local Therapies: Reality Versus Illusion
por: Tran, Phuoc T., et al.
Publicado: (2017)

Future Prospects in the Diagnosis and Management of Localized Prostate Cancer
por: Tefekli, Ahmet, et al.
Publicado: (2013)

Optimizing the Management of High-Risk, Localized Prostate Cancer
por: Sundi, Debasish, et al.
Publicado: (2012)

The effects of testosterone replacement therapy on the prostate: a clinical perspective
por: Miah, Saiful, et al.
Publicado: (2019)

Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management
por: Tonry, Claire, et al.
Publicado: (2020)

Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups
por: McHugh, Jana, et al.
Publicado: (2021)

Advances in Localized Prostate Cancer Management
por: Samadi, David B., et al.
Publicado: (2018)

PROTACs in the Management of Prostate Cancer
por: Yedla, Poornachandra, et al.
Publicado: (2023)

Men's preferences for prostate cancer screening: a discrete choice experiment
por: de Bekker-Grob, E W, et al.
Publicado: (2013)

Immune globulin therapy and kidney disease: Overview and screening, monitoring, and management recommendations
por: Kobayashi, Roger H, et al.
Publicado: (2022)

Clinical Management of Localized Colon Cancer with Capecitabine
por: Quidde, J., et al.
Publicado: (2012)

A Case-Based Clinical Approach to the Investigation, Management and Screening of Families with BRCA2 Related Prostate Cancer
por: King, Bradley, et al.
Publicado: (2021)

The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review
por: Yuan, Peng, et al.
Publicado: (2020)

Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer
por: Lehrer, S, et al.
Publicado: (2002)

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer
por: Thuret, R, et al.
Publicado: (2005)

Screening for Prostate Cancer by Digital Rectal Examination and PSA Determination in Senegal
por: Niang, Lamine, et al.
Publicado: (2011)

Prostate cancer screening in Europe and Asia
por: Zhang, Kai, et al.
Publicado: (2017)

Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
por: Moschini, Marco, et al.
Publicado: (2016)

Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
por: Broncy, Lucile, et al.
Publicado: (2019)

Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China
por: Zhang, J., et al.
Publicado: (2016)

Diagnosis of prostate cancer in primary care: navigating updated clinical guidance
por: Merriel, Samuel WD, et al.
Publicado: (2023)

Role of mpMRI of the prostate in screening for prostate cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2017)

Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis
por: Willis, Sarah R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_74e2emg9hqtp79tm00301h2u16